These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 24929356

  • 1. An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data.
    Vajdic CM, Er CC, Schaffer A, Dobbins T, Wyld L, Meagher NS, Barrett J, Ward RL, Pearson SA.
    Cancer Epidemiol; 2014 Aug; 38(4):460-4. PubMed ID: 24929356
    [Abstract] [Full Text] [Related]

  • 2. Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care.
    Luke C, Koczwara B, Karapetis C, Pittman K, Price T, Kotasek D, Beckmann K, Brown MP, Roder D.
    Aust N Z J Public Health; 2008 Aug; 32(4):383-9. PubMed ID: 18782405
    [Abstract] [Full Text] [Related]

  • 3. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA.
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [Abstract] [Full Text] [Related]

  • 4. Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients.
    Schaffer AL, Pearson SA, Dobbins TA, Er CC, Ward RL, Vajdic CM.
    Cancer Epidemiol; 2015 Aug; 39(4):578-84. PubMed ID: 26100364
    [Abstract] [Full Text] [Related]

  • 5. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis.
    Bevier M, Sundquist J, Hemminki K.
    Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673
    [Abstract] [Full Text] [Related]

  • 6. Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP).
    Vajdic CM, Perez-Concha O, Dobbins T, Ward RL, Schaffer AL, van Leeuwen MT, Rhee JJ, Laaksonen MA, Craigen G, Pearson SA.
    Cancer Epidemiol; 2019 Jun; 60():156-161. PubMed ID: 31015097
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rapid reduction in the incidence of cancer of unknown primary. A population-based study.
    Brustugun OT, Helland Å.
    Acta Oncol; 2014 Jan; 53(1):134-7. PubMed ID: 23550957
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry.
    Luo Q, Yu XQ, Cooke-Yarborough C, Smith DP, O'Connell DL.
    Cancer Epidemiol; 2013 Dec; 37(6):813-9. PubMed ID: 24103424
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP).
    Schaffer AL, Pearson SA, Perez-Concha O, Dobbins T, Ward RL, van Leeuwen MT, Rhee JJ, Laaksonen MA, Craigen G, Vajdic CM.
    PLoS One; 2020 Dec; 15(3):e0230373. PubMed ID: 32191753
    [Abstract] [Full Text] [Related]

  • 12. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
    Randén M, Rutqvist LE, Johansson H.
    Acta Oncol; 2009 Dec; 48(6):915-20. PubMed ID: 19363713
    [Abstract] [Full Text] [Related]

  • 13. Cancer of unknown primary: time trends in incidence, United States.
    Mnatsakanyan E, Tung WC, Caine B, Smith-Gagen J.
    Cancer Causes Control; 2014 Jun; 25(6):747-57. PubMed ID: 24710663
    [Abstract] [Full Text] [Related]

  • 14. Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP).
    Vajdic CM, Perez-Concha O, Rhee JJ, Dobbins T, Ward RL, Schaffer AL, van Leeuwen MT, Laaksonen MA, Craigen G, Pearson SA.
    Cancer Epidemiol; 2019 Aug; 61():1-7. PubMed ID: 31082704
    [Abstract] [Full Text] [Related]

  • 15. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model.
    Hemminki K, Pavlidis N, Tsilidis KK, Sundquist K, Ji J.
    Sci Rep; 2016 Mar 24; 6():23725. PubMed ID: 27009354
    [Abstract] [Full Text] [Related]

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Mar 24; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 17. Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity.
    Dyrvig AK, Yderstræde KB, Gerke O, Jensen PB, Hess S, Høilund-Carlsen PF, Green A.
    Medicine (Baltimore); 2017 Apr 24; 96(16):e6693. PubMed ID: 28422885
    [Abstract] [Full Text] [Related]

  • 18. Descriptive epidemiology of cancer of unknown primary in South Korea, 1999-2017.
    Boo YK, Park D, Lim J, Lim HS, Won YJ.
    Cancer Epidemiol; 2021 Oct 24; 74():102000. PubMed ID: 34364188
    [Abstract] [Full Text] [Related]

  • 19. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K, Sundquist K, Sundquist J, Hemminki A, Ji J.
    Sci Rep; 2016 Mar 09; 6():22891. PubMed ID: 26956545
    [Abstract] [Full Text] [Related]

  • 20. Cancer of Unknown Primary: a Cancer Registry Study of Factors Affecting Access to Diagnosis.
    Crawford SM, Skinner J, Coombes E, Jones AP.
    Clin Oncol (R Coll Radiol); 2017 Jan 09; 29(1):e39-e46. PubMed ID: 27720362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.